Clinica Baviera (XMAD:CBAV) E10: €1.66 (As of Mar. 2026)


XMAD:CBAV Clinica Baviera SA XMAD:CBAV
100 GF Score
Price €56.60
GF Value €41.30
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Clinica Baviera E10?

Clinica Baviera XMAD:CBAV +0.71% 100 E10 is €1.66 as of Mar. 2026. GuruFocus rates XMAD:CBAV with a GF Score™ of 100/100 and a GF Value™ of €41.30 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Clinica Baviera's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.917. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €1.66 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Clinica Baviera's average E10 Growth Rate was 18.60% per year. During the past 3 years, the average E10 Growth Rate was 22.70% per year. During the past 5 years, the average E10 Growth Rate was 26.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Clinica Baviera was 29.70% per year. The lowest was 22.70% per year. And the median was 26.15% per year.

As of today (2026-06-25), Clinica Baviera's current stock price is €56.60. Clinica Baviera's E10 for the quarter that ended in Mar. 2026 was €1.66. Clinica Baviera's Shiller PE Ratio of today is 34.10.

During the past 13 years, the highest Shiller PE Ratio of Clinica Baviera was 37.81. The lowest was 17.78. And the median was 26.02.


Clinica Baviera  (XMAD:CBAV) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Clinica Baviera's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=56.60/1.66
=34.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Clinica Baviera was 37.81. The lowest was 17.78. And the median was 26.02.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Clinica Baviera E10 Related Terms


Clinica Baviera E10 Historical Data

* Premium members only.

The historical data trend for Clinica Baviera's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinica Baviera E10 Chart

Clinica Baviera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.86 1.07 1.32 1.59

Clinica Baviera Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 1.47 1.50 1.59 1.66

XMAD:CBAV vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, Clinica Baviera's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinica Baviera Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Clinica Baviera's Shiller PE Ratio falls into.


XMAD:CBAV
100GF Score
Clinica Baviera SA XMAD:CBAV
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinica Baviera E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Clinica Baviera's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.917/128.4016*128.4016
=0.917

Current CPI (Mar. 2026) = 128.4016.

Clinica Baviera Quarterly Data

per share eps CPI Adj_EPS
201606 0.139 100.333 0.178
201609 0.056 99.737 0.072
201612 0.111 101.842 0.140
201703 0.160 100.896 0.204
201706 0.142 101.848 0.179
201709 0.101 101.524 0.128
201712 0.197 102.975 0.246
201803 0.243 102.122 0.306
201806 0.183 104.165 0.226
201809 0.069 103.818 0.085
201812 0.231 104.193 0.285
201903 0.224 103.488 0.278
201906 0.215 104.612 0.264
201909 0.091 103.905 0.112
201912 0.255 105.015 0.312
202003 0.130 103.469 0.161
202006 0.059 104.254 0.073
202009 0.286 103.521 0.355
202012 0.380 104.456 0.467
202103 0.480 104.857 0.588
202106 0.506 107.102 0.607
202109 0.355 107.669 0.423
202112 0.339 111.298 0.391
202203 0.681 115.153 0.759
202206 0.493 118.044 0.536
202209 0.308 117.221 0.337
202212 0.328 117.650 0.358
202303 0.712 118.948 0.769
202306 0.576 120.278 0.615
202309 0.364 121.343 0.385
202312 0.555 121.300 0.587
202403 0.762 122.762 0.797
202406 0.677 124.409 0.699
202409 0.287 123.121 0.299
202412 0.762 124.753 0.784
202503 0.804 125.531 0.822
202506 0.590 127.251 0.595
202509 0.373 126.842 0.378
202512 0.859 128.402 0.859
202603 0.917 128.402 0.917

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €1.66 mean?
Clinica Baviera (XMAD:CBAV) has a E10 of €1.66 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Clinica Baviera and its competitors.
Is Clinica Baviera's E10 too high?
Clinica Baviera's current E10 is €1.66. Overall, Clinica Baviera has a GF Score™ of 100/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clinica Baviera's E10 compare to TMO and DHR?
Clinica Baviera's E10 of €1.66 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Clinica Baviera and its competitors. Clinica Baviera's current E10 is €1.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica Baviera stock overvalued right now?
Based on GuruFocus' analysis, Clinica Baviera (XMAD:CBAV) is currently considered Significantly Overvalued. The stock's GF Value™ is €41.30, compared to a current price of €56.60 — trading 37% above its estimated fair value. The current E10 is €1.66. Clinica Baviera's overall GF Score™ is 100/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Clinica Baviera (XMAD:CBAV), the current E10 is €1.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clinica Baviera (XMAD:CBAV) Overvalued in 2026?

Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued. The current stock price of €56.60 is trading 37% above its estimated GF Value™ of €41.30. GuruFocus considers Clinica Baviera to be Significantly Overvalued.

Key valuation signals for XMAD:CBAV:

  • E10: €1.66
  • GF Value™: €41.30 vs. price of €56.60 (37% above fair value)
  • GF Score™: 100/100 with 4 warning signs

No single metric tells the full story. See the XMAD:CBAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clinica Baviera Business Description

Other Exchanges 0GWJ:UKD9Z:Germany
Address Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
100GF Score

Get the complete analysis for XMAD:CBAV

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€56.60
Price
€41.30
GF Value